Automated platform for cell therapy manufacturing at scale
Limula SA
Incorporated
06.11.2020Headquarters
La Tour-de-PeilzSupport
Limula SA is based in Lausanne, Switzerland, looking to disrupt the status quo in the manufacturing of Cell & Gene Therapies. The company brings a novel approach to automation, offering the biopharma industry a fully autonomous, end-to-end platform—much like a nespresso machine for cell therapy production. Their mission is to support rapid and cost-effective introduction of new advanced therapy products to the market. Their platform leverages a proprietary combination of hardware, consumable and software to bring all functionalities required for on-demand and at-scale manufacturing of cell therapies in a single device. With its revolutionary solution, Limula is unlocking a nascent market that has grown from $150m to $2.5B+ between 2018 and 2024, and yet has less than 10% penetration today.
News
Swiss Economic Award 2026: Nine start-ups progress to the final (startupticker.ch)
Limula transitions to commercial phase (startupticker.ch)
Three life sciences startups recognized for growth potential (startupticker.ch)
Breakthrough Solution in end-to-end cell therapy manufacturing unveiled (startupticker.ch)
Limula, Actival and AirCurve get FIT backing (startupticker.ch)
The most promising Swiss biotech startups and scale-ups of 2024, according to investors (TOP 100)
Two weeks in Silicon Valley (startupticker.ch)
Limula raises $6.8M to scale cell and gene therapies (startupticker.ch)
Limula secures USD 6.8 million to revolutionize Cell and Gene Therapy manufacturing (venturelab.swiss)
Third LeadiNNg to Scale-Up Cohort unveiled (startupticker.ch)
ZKB Pionierpreis Technopark shortlists 11 startups (startupticker.ch)
Novel collaboration opens up EPFL's talent pool to Biopôle start-ups (startupticker.ch)
Limula wins $250,000 Grand Prize at global innovation award (startupticker.ch)
Three start-ups win Biopôle Funding (startupticker.ch)
Venture Leaders Biotech 2023: Captain’s Blog by Navignostics, Mosanna Therapeutics, Limula, and Tandem Therapeutics (venturelab.swiss)
Cleantech and life sciences start-ups scoop prizes at W.A. de Vigier Awards (startupticker.ch)
The Venture Leaders Biotech set sail on the Boston roadshow with immersive expert workshops, uniting entrepreneurs and investors in the US market (venturelab.swiss)
Limula: The Venture Leader Biotech on a mission to make the most personalized cancer treatments possible (venturelab.swiss)
Swiss Accelerator: Innosuisse supports 53 companies with CHF112 million (startupticker.ch)
Milestones news
Venture Kick - Round 1
La Forge MedTech Acceleration Program
Documents
